Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Lin H et al. | 1999 | intact cell/cell culture, HeLa cell line (human adenocarcinoma cell line), transfected | magnetic field, 50/60 Hz | 8 µT |
Lin H et al. | 2001 | intact cell/cell culture, HeLa cell line (human adenocarcinoma cell line), transfected | magnetic field, 50/60 Hz | 8 µT |
Manzella N et al. | 2015 | intact cell/cell culture, HuDe cells (human dermal fibroblasts) | magnetic field, 50/60 Hz | 0.1 mT |
Rao RR et al. | 2002 | intact cell/cell culture, IMR 32 (human neuroblastoma cells) | magnetic field, 50/60 Hz | 50–200 µT |
Heredia-Rojas JA et al. | 2010 | intact cell/cell culture, INER-37 (human non-small-cell lung cancer cell line) and RMA E7 cells (E7-transfected mouse RMA lymphoma cells), transfected with the plasmid pEMF (electromagnetic field plasmid containing hsp70 promotor and the luciferase gene as reporter gene) | magnetic field, 50/60 Hz | 8–80 µT |
Still M et al. | 2002 | intact cell/cell culture, Jurkat cells (clone E6-1; T-lymphocyte hybridoma cell line) | magnetic field, 50/60 Hz, DC, static magnetic field | 10–100 µT |
Patruno A et al. | 2015 | intact cell/cell culture, K562 cells (human erythroleukemic cell line) | magnetic field, 50/60 Hz | 1 mT |
Jedrzejczak-Silicka M et al. | 2021 | intact cell/cell culture, L929 cells (murine fibroblast cells) and HaCaT cells (human keratinocytes cell line) | magnetic field, 50/60 Hz, low frequency | 5.9–28.4 mT |
Girgert R et al. | 2008 | intact cell/cell culture, MCF-7 (breast cancer cell line, p40 and p181 clone) | magnetic field, low frequency, 50/60 Hz | 1.2 µT |
Girgert R et al. | 2009 | intact cell/cell culture, MCF-7 (breast cancer cell line, p40 and p181 clone) | magnetic field, low frequency, 50/60 Hz | 1.2 µT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.